Clinical Trials Browser

OTHER × Neoplasms × Endostatins × Clear all

NCT06047860 2023-09-21

A Clinical Study of Recombinant Human Vascular Endothelial Inhibitor in Combination With PRaG for Advanced Refractory Non-small Cell Lung Cancer

Phase 2 Unknown

Neoplasms

NCT00262327 2006-06-20

Safety and Efficacy of Adenoviral Endostatin in the Treatment of Advanced Solid Tumor

Phase 1 Unknown

Adenoviridae Infections, Neoplasms